Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pluri CEO Yaky Yanay letter published in the New York Daily News !
https://pluri-biotech.com/wp-content/uploads/2023/12/Brutal-war-cant-dim-Israels-economic-miracle.pdf
Ever After Foods CEO Interviewed For This Article On Pages 16 & 17 !!!
https://bt.e-ditionsbyfry.com/publication/frame.php?i=808464&p=16&pn=&ver=html5&view=issueViewer
International Patent Posted !!!
WO2023228182 - SYSTEM AND METHODS FOR IMMUNE CELLS EXPANSION AND ACTIVATION IN LARGE SCALE
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023228182&_cid=P22-LPMT5T-70742-1
Andy Lewin Chief Commercial Officer - PluriCDMO
https://pluri-biotech.com/our-story-team/
PluriCDMO.... Contract Development Manufacturing Organization
https://pluri-biotech.com/our-story-team/
This Is BIG NEWS !!!
1. US20230374433 - SYSTEM AND METHODS FOR IMMUNE CELLS EXPANSION AND ACTIVATION IN LARGE SCALE
[color=red]Published On Thanksgiving !!!
https://patentscope.wipo.int/search/en/detail.jsf?docId=US414867681&_cid=P11-LPEFAE-21224-1
More Tutes Coming In !!!
https://fintel.io/so/us/psti
Renaissance Technologies LLC Bought 52,700 Shares Today Bringing Their Total Holdings To 157,900 !!!
https://fintel.io/so/us/psti
Wow !!! Incredible Plant Cell Patent Published On November 9th !!!
https://patentscope.wipo.int/search/en/detail.jsf?docId=US413449951&_cid=P12-LOUROG-42735-1
Holy Grail !!! Incredible !!!
In certain embodiments, the induced ASC secrete neurotrophic and neuroprotective growth factors. In more specific embodiments, the neurodegenerative disease is Alzheimer's disease; Parkinson's disease; is Amyotrophic lateral sclerosis (ALS); is Huntington's disease; or is SMA, each of which represents a separate embodiment. In still other embodiments, the neurological disease is multiple sclerosis (MS), or is ataxia-telangiectasia.
https://patentscope.wipo.int/search/en/detail.jsf?docId=US300735826&_fid=IL406584960
WOW !!!
A composition for treating Amyotrophic Lateral Sclerosis (ALS), comprising induced placental adherent stromal cells (ASC), wherein said induced placental ASC are generated by: (i) expanding placental ASC in an expansion medium lacking
heparin and cAMP, thereby generating expanded placental ASC; and (ii) inducing said expanded placental ASC by incubating said expanded placental ASC in a bioreactor, and wherein said induced placental ASC are indicated for intrathecal administration.
https://patentscope.wipo.int/search/en/detail.jsf?docId=IL406584960&_cid=P12-LNYSXQ-76811-1
On October 17, 2023, the Company received a letter (the “Letter”), from the Staff approving an extension of an additional 180 calendar days from the date of the Letter, or until April 15, 2024 (the “Additional Compliance Period”) to regain compliance with the Minimum Bid Price Requirement as well as approving the Company’s application to transfer its securities from the Nasdaq Global Market to The Nasdaq Capital Market starting at the opening of business on October 19, 2023. The Company’s Common Shares will continue to trade under the symbol “PLUR.” The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1158780/000101376223005107/ea187002-8k_pluriinc.htm
UK rejigs rules and promises 14-day approvals for low-risk clinical trials
https://informaconnect.com/uk-rejigs-rules-and-promises-14-day-approvals-for-low-risk-clinical-trials/
The newspaper says the UK is set to sign a deal with Israel to boost collaboration on cell-cultured meat.
GIDDY-UP !!!
https://www.greenqueen.com.hk/uk-set-to-fast-track-cultivated-meat-approval-israel-partnership-the-telegraph-aleph-farms/
Impressive !!!
It's Looking Like Ever After Foods Will Be Able To Grow A Full Cut Of Meat In Just 48 Hours !!! WOW !!! It Takes 2-3 Years For A Beef Cow To Grow !!!
Dr. Tamar Eigler Hirsh, CTO of Profuse, added that the company’s “proprietary supplements and protocols achieve effective production in a 3D environment without resorting to genetic modification or any undesirable elements.”
https://www.jpost.com/business-and-innovation/article-760826
The Big Players Know What's Coming !!!
https://www.msn.com/en-us/money/companies/signal-jbs-pushes-forward-with-fresh-investment-in-cell-based-meat/ar-AA1h6Fxb
The Big Players Know What's Coming !!!
https://www.msn.com/en-us/money/companies/signal-jbs-pushes-forward-with-fresh-investment-in-cell-based-meat/ar-AA1h6Fxb
Good News !!!
Pluri Just Activated The 200 Million ! Potential For A Deal Next Week ? TASE Opens On Tuesday ! FOMO RALLY ???
GIDDY-UP !!!
https://www.sec.gov/cgi-bin/browse-edgar?CIK=0001158780&owner=exclude
Pluri Report Out !!!
Pluri is at the forefront of this extraordinary new world.
Our state-of-the-art, proprietary bioreactor system – developed over many years during our work in regenerative medicine –
provides a 3D micro-environment for cells, resembling their natural environment.
Our advanced manufacturing technology is tightly controlled, completely automated, efficient and scalable. It can generate
high-quality cell products on a mass scale with batch-to-batch consistency, whether these cells derive from humans, plants or
animals. Our cell expansion platforms are emerging as the new gold standard to accelerate creation of cell-based solutions.
https://pluri-biotech.com/wp-content/uploads/2023/09/Pluri-Report-2023-final.pdf
September Company Presentation Is Out:
https://pluri-biotech.com/wp-content/uploads/2023/09/Pluri-PPT-investor_Q4_2023.pdf
METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
https://patentscope.wipo.int/search/en/detail.jsf?docId=IL406584960&_cid=P10-LMP4I6-98871-1
FYI: I Have Never Posted A Single Word About Pluripotent Cells. You Are Delusional...Again !!!
The global Sarcopenia treatment market size was valued at $2.6 Billion in 2020, and is projected to reach $4.7 Billion by 2030,
IMO...Pluri Will Own This Indication And Every Other Muscle-Wasting Indication....Watch & Learn...... The PLX-Cell Destiny Dance !!!
FYI: Growing Various Types Of Activated Immune Cells At Scale Is....Very Rare !!!
I Did Find 1 Bioreactor Company in Germany That Did A Proof Of Concept Study In Which They Were Able To Grow Activated NK Immune Cells At Scale. Lets Wait And See Which Immune Cells Pluri Can Grow, As There Are Many Different Types Of Immune Cells.
Immune Cells...A BIG NO !!! YOU ARE COMPLETELY CLUELESS...PROVE ME WRONG !!!
Wow... Very Impressive !!! As Far As I Know....Pluri Is The Only Company In The World That Can Do It At LARGE SCALE AND ACTIVATION ???
NICE.... Last Patent Listed In The 10K Annual Report !!!
SYSTEM AND METHODS FOR IMMUNE CELLS EXPANSION AND ACTIVATION IN LARGE SCALE
PCT/IL2023/050529 PCT, United States Expires: May 23, 2043
Register To Listen To Yaky's Presentation Today At 1:00 PM EST !!!
https://www.inpeak.xyz/events
So Glad You Remain Completely Clueless !!! IMO...Current Pluri Shareholders (All 52 Of Them ) Will Be Laughing At You Soon !!!
As of September 8, 2023, there were 52 holders of record, and 41,351,870 of our common shares were issued and outstanding.
Since PLX-R18 cannot be studied using human subjects for ethical reasons, it is being considered for approval through what is called the FDA’s Animal Rule and the European Medicines Agency’s Exceptional Circumstances Pathway. For this reason, the authorities are asking Pluri and its research partners for more refinement.
https://www.timesofisrael.com/israels-pluri-wins-nih-contract-for-drug-that-could-save-lives-in-nuclear-event/
From Annual Report: On September 7, 2023, we provided a formal notice of termination of the ATM Agreement with Jefferies, which took effect on September 8, 2023
NICE.... Last Patent Listed In The 10K Annual Report Today !!!
SYSTEM AND METHODS FOR IMMUNE CELLS EXPANSION AND ACTIVATION IN LARGE SCALE
PCT/IL2023/050529 PCT, United States Expires: May 23, 2043
From Nuclear Bombs to Frail Bones: New Study Highlights Promise of Israeli Cell Therapy for Blood Disorders
Based in Haifa, Pluri is seen as one of Israel’s most innovative companies and a proven pioneer in cell replication technology.
https://jewishjournal.com/culture/health/362366/from-nuclear-bombs-to-frail-bones-new-study-highlights-promise-of-israeli-cell-therapy-for-blood-disorders/